REPORTS

Let’s Pullulate and Expand Your Business

Naloxone Market - Global Professional Analysis and Forecast to 2026

Mar 09, 2020  |  211 PAGES  |  REPORT CODE: CMM270846
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Naloxone market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.8% during the forecast period.

This report presents the market size and development trends by detailing the Naloxone market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Naloxone market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Naloxone industry and will help you to build a panoramic view of the industrial development.

Naloxone Market, By Type:

  • Spray forms

  • Injectable forms

Naloxone Market, By Application:

  • Opioid overdose

  • Preventing opioid abuse

Some of the leading players are as follows:

  • kaleo

  • Mylan

  • Pfizer

  • Sandoz

  • ADAPT Pharma

  • Amneal Pharmaceuticals

  • West Ward Pharmaceuticals

  • Amphastar Pharmaceuticals

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Naloxone Market: Technology Type Analysis

  • 4.1 Naloxone Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Naloxone Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Spray forms

    • 4.3.2 Injectable forms

5 Naloxone Market: Product Analysis

  • 5.1 Naloxone Product Market Share Analysis, 2018 & 2026

  • 5.2 Naloxone Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Naloxone Market: Application Analysis

  • 6.1 Naloxone Application Market Share Analysis, 2018 & 2026

  • 6.2 Naloxone Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Opioid overdose

    • 6.3.2 Preventing opioid abuse

7 Naloxone Market: Regional Analysis

  • 7.1 Naloxone Regional Market Share Analysis, 2018 & 2026

  • 7.2 Naloxone Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 kaleo

    • 9.1.1 kaleo Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Mylan

    • 9.2.1 Mylan Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Pfizer

    • 9.3.1 Pfizer Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sandoz

    • 9.4.1 Sandoz Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 ADAPT Pharma

    • 9.5.1 ADAPT Pharma Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Amneal Pharmaceuticals

    • 9.6.1 Amneal Pharmaceuticals Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 West Ward Pharmaceuticals

    • 9.7.1 West Ward Pharmaceuticals Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Amphastar Pharmaceuticals

    • 9.8.1 Amphastar Pharmaceuticals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

 

The List of Tables and Figures (Totals 61 Figures and 137 Tables)

  • Figure Spray forms Naloxone market, 2015 - 2026 (USD Million)

  • Figure Injectable forms Naloxone market, 2015 - 2026 (USD Million)

  • Figure Opioid overdose market, 2015 - 2026 (USD Million)

  • Figure Preventing opioid abuse market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Naloxone market, by country, 2015 - 2026 (USD Million)

  • Table North America Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table North America Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table North America Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Canada Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Canada Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Europe Naloxone market, by country, 2015 - 2026 (USD Million)

  • Table Europe Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Europe Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Europe Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Germany Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Germany Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table France Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table France Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Italy Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Italy Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Spain Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Spain Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Naloxone market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table China Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table China Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Japan Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Japan Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table India Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table India Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Naloxone market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table MEA Naloxone market, by country, 2015 - 2026 (USD Million)

  • Table MEA Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table MEA Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table MEA Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Naloxone market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Naloxone market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Naloxone market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table kaleo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sandoz Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ADAPT Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amneal Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table West Ward Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amphastar Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top